Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders (Q35653942)

9 August 2017

1 reference

title

Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders (English)

1 reference

9 August 2017

I. S. Fraser

1

1 reference

PubMed ID

1478000

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1478000

30 September 2022

language of work or name

1 reference

1 December 1992

1 reference

Bailliere's clinical obstetrics and gynaecology

9 August 2017

1 reference

9 August 2017

6

1 reference

9 August 2017

4

1 reference

9 August 2017

829-857

1 reference

The effect of 17 beta-estradiol and progesterone on prostaglandin production by human endometrium maintained in organ culture

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Differential production of prostaglandins within the human uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Increased uterine prostaglandin E receptors in menorrhagic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

The microvasculature of common uterine abnormalities, other than fibroids

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Treatment of functional menstrual disorders with norethisterone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Preliminary observations on urinary oestrogen excretion in certain gynaecological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Endometrial prostaglandins in women with abnormal menstrual bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Involvement of lipoxygenase products in myometrial contractions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Prostaglandin inhibitors in gynaecology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Treatment of menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Blood production and ovarian secretion rates of estradiol-17 beta and estrone in women with dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Hysteroscopy and laparoscopy in women with menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Pituitary gonadotropins and ovarian function in adolescent dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

A preliminary study of factors influencing perception of menstrual blood loss volume

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Endometrial blood flow measured by xenon 133 clearance in women with normal menstrual cycles and dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Presence of gap junctions in the myometrium of women during various stages of menstruation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Menstrual Blood Loss–A Population Study: Variation at different ages and attempts to define normality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Anaprox in dysmenorrhea: Reduction of pain and intrauterine pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Nonpigmented endometriosis: clinical, laparoscopic, and pathologic definition

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Prostaglandins as modulators of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Prostaglandin biosynthesis inhibitors and endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Catechol oestrogens stimulate and direct prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Intra-uterine pressure in dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Ibuprofen prevents IUCD-induced increases in menstrual blood loss

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Mefenamic acid in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Treatment of menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

The potential for the use of GnRH agonists for treatment of dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

PROSTAGLANDINS IN ENDOMETRIUM AND MENSTRUAL FLUID FROM NORMAL AND DYSMENORRHOEIC SUBJECTS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Uterine cavity and the location of IUDs following administration of meclofenamic acid to menorrhagic women. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

The distribution of endometriosis in the pelvis by age groups and fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Endometrial and myometrial prostaglandin release during the menstrual cycle in relation to menstrual blood loss

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Effect of fenamates on prostaglandin E receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Surgical induction of endometriosis in the rabbit: effects on fertility and concentrations of peritoneal fluid prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Etiology of infertility in monkeys with endometriosis: measurement of peritoneal fluid prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Dysmenorrhea and Uterine Neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Pressure-velocity analysis of uterine muscle during spontaneous dysmenorrheic contractions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

A role for prostacyclin (PGi2) in excessive menstrual bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

The synthesis of prostaglandins from persistent proliferative endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Peritoneal fluid environment and infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Gestrinone in the treatment of menorrhagia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Hypothalamic-pituitary-ovarian function in perimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Impaired Estrogen-Induced Luteinizing Hormone Release in Young Women with Anovulatory Dysfunctional Uterine Bleeding*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Treatment of menorrhagia with meclofenamate sodium.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Studies in the involvement of prostaglandins in uterine symptomatology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980191-9

7 January 2021

10.1016/S0950-3552(05)80191-9

Identifiers

DOI

1 reference

release_wtkkxuuhojb2nfynojc4gps3bu

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wtkkxuuhojb2nfynojc4gps3bu

24 November 2022

mapped directly with Wikidata item

PubMed ID

1478000

1 reference

PubMed ID

1478000